Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer - The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):: A Randomized Trial of Intravesical Epirubicin at Dose of 20 mg/40 ml, 30 mg/40 ml, 40 mg/40 ml

Masao Kuroda, Tadao Niijima, Toshihiko Kotake, Hideyuki Akaza, Shiro Hinotsu

Research output: Contribution to journalArticle

39 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer - The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):: A Randomized Trial of Intravesical Epirubicin at Dose of 20 mg/40 ml, 30 mg/40 ml, 40 mg/40 ml'. Together they form a unique fingerprint.

Medicine & Life Sciences